<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2019-12-02">
  <drugbank-id primary="true">DB11150</drugbank-id>
  <name>Barium sulfate</name>
  <description>Barium sulfate is an inorganic compound with the chemical formula BaSO4 [L1957].&#13;
&#13;
Barium sulfate occurs in nature as the mineral _barite_. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield [L1957].&#13;
&#13;
This drug is used as a contrast agent in diagnostic x-ray procedures. Therapeutic advantages of barium sulfate in diagnostic procedures include both its low water solubility and high level of clearance from the body [FDA label].&#13;
&#13;
Barium sulfate is ingested by mouth or administered rectally and combined with granules of effervescent bicarbonate to enhance distension of the GI tract, allowing for enhanced gastrointestinal tract visualization [L1957], [L1959].</description>
  <cas-number>7727-43-7</cas-number>
  <unii>25BB7EKE2E</unii>
  <average-mass>233.39</average-mass>
  <monoisotopic-mass>233.856970451</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32328</ref-id>
        <pubmed-id>1889235</pubmed-id>
        <citation>Williams SM, Harned RK: Recognition and prevention of barium enema complications. Curr Probl Diagn Radiol. 1991 Jul-Aug;20(4):123-51.</citation>
      </article>
      <article>
        <ref-id>A32329</ref-id>
        <pubmed-id>12865956</pubmed-id>
        <citation>Hoevels J, Thermann M: [Barium sulfate and water-soluble contrast medium--a suitable mixture for contrast radiography in acute small bowel obstruction]. Zentralbl Chir. 2003 Jun;128(6):500-5. doi: 10.1055/s-2003-40624.</citation>
      </article>
    </articles>
    <textbooks/>
    <links>
      <link>
        <ref-id>L1957</ref-id>
        <title>Barium Sulfate  PubChem</title>
        <url>https://pubchem.ncbi.nlm.nih.gov/compound/barium_sulfate</url>
      </link>
      <link>
        <ref-id>L1958</ref-id>
        <title>Barium Sulfate, Drugs.com</title>
        <url>https://www.drugs.com/mmx/barium-sulfate.html</url>
      </link>
      <link>
        <ref-id>L1959</ref-id>
        <title>NDA, Barium Sulfate</title>
        <url>https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM489008.pdf</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication> Barium sulfate is a radiographic contrast agent indicated for use in computed tomography (CT) of the abdomen to delineate the gastrointestinal (GI) tract in adult and pediatric patients [FDA label].</indication>
  <pharmacodynamics>Barium sulfate increases the absorption of x-rays as they are passed throughout the body, delineating body structures, in which barium sulfate is localized. This allows for the clear visualization of normal organs/defect in normal anatomy [L1959].</pharmacodynamics>
  <mechanism-of-action>Barium sulfate is a heavy metal with a high atomic number (Z=56) and a K shell binding energy (K-edge of 37.4 keV) very close to that of most diagnostic x-ray beams. Due to these characteristics, barium is an ideal medium for the absorption of x-rays [FDA label].&#13;
&#13;
Barium sulfate is essentially not absorbed from the GI tract nor metabolized in the body. Barium sulfate is used to fill the gastrointestinal tract lumen or to coat the mucosal surface and is administered orally, rectally, or instilled into an enterostomy tube or catheter [FDA label], [L1959].&#13;
&#13;
Barium sulfate enhances delineation of the GI tract. The barium suspension covers the mucosal surface of the GI tract, allowing its shape, distensibility, motion, integrity, continuity, location within the torso, relationship to other organs to be closely examined [L1959].  Various abnormalities, such as benign or malignant tumors, ulcers, strictures, diverticula, inflammation or infection, altered motility, displacement and other pathology can thereby be identified [FDA label], [L1959].&#13;
&#13;
At lower concentrations (higher dilution), barium enhances the conspicuity of the GI tract to differentiate the GI tract from various abdominal organs in computed tomography examinations (CT scans) of the abdomen. Improved delineation of the gastrointestinal tract lumen and mucosa may be reached by contrast provided by gas (by the addition of bicarbonate or gas-filled balloons) in addition to the barium [L1959].   This is known as a _double-contrast procedure_. Osmotically active agents (for example, sorbitol) are also used to induce fluid accumulation and distension of the GI system to enhance visualization [L1959].</mechanism-of-action>
  <toxicity>&#13;
&#13;
**Acute Exposure**&#13;
&#13;
Nausea, vomiting, diarrhea and abdominal cramping may occur [FDA label]. Acute exposure to barium sulfate may irritate the eyes and respiratory tract. Exposure to inhalation or other forms can affect the nervous system and lead to hypokalemia, which can contribute to cardiovascular rhythm abnormality [L1957]. Hypersensitivity, gastrointestinal transit delay, obstruction, aspiration pneumonitis and systemic embolization of barium sulfate are more serious complications of administration [FDA label]. In addition, fatalities have occurred due to aspiration pneumonitis, barium sulfate impaction, intestinal perforation with subsequent peritonitis and granuloma formation, and vasovagal and syncopal episodes [FDA label], [A32329].&#13;
&#13;
**Chronic Exposure **&#13;
&#13;
The lungs may be affected by repeated or prolonged exposure to dust particles, resulting in baritosis (a type of benign pneumoconiosis) [L1957]. Inhalation of barium sulfate dust may lead to a benign pneumoconiosis ("baritosis") with conspicuous radiographic characteristics but no signs of impairment of pulmonary function [L1957].&#13;
&#13;
**Intra-abdominal leakage**&#13;
&#13;
Intra-abdominal leakage may occur during or after administration of barium sulfate [FDA label}. Caution is advised in several patient conditions such as fistulas, ulcer, inflammatory bowel disease, appendicitis/diverticulitis, severe stenosis or obstruction of the GI tract. Patients should maintain adequate hydration for several days following a barium sulfate procedure to prevent obstruction or impaction caused by batholiths (barium sulfate stones) [L1959]. Caution is advised in patients with a history of food aspiration and in patients with diagnosed swallowing disorders [FDA label].&#13;
&#13;
** A note on GI perforation**&#13;
&#13;
Perforation of the colon after rectal administration of barium sulfate suspension has been reported due to the increased hydrostatic pressure of the instilled suspension, trauma to the colon from an enema tip, or forceful or deep insertion of a non-flexible enema tip. Perforation of the bowel has been followed by peritonitis, adhesions, granulomas, and death [L1958].  This is a rare occurrence.  Injury to the rectal mucosa or anal canal due to the enema tip or retention balloon is likely the most common traumatic cause of perforation during treatment. Inflation of a balloon within a stricture, neoplasm, inflamed rectum, or stoma is hazardous, and caution should be exerted [A32328]. &#13;
&#13;
**Carcinogenicity and mutagenicity**&#13;
&#13;
No animal studies have been performed to evaluate the carcinogenicity of barium sulfate or potential effects on reproduction [FDA label]. Elective contrast radiography of the abdomen is not routintely recommended during pregnancy because of the risks to the fetus from radiation exposure [L1958].</toxicity>
  <metabolism>Barium sulfate is poorly water soluble and shows negligible levels of absorption from the gastrointestinal tract following both oral or rectal administration.  In healthy subjects, orally administered barium sulfate is generally excreted within 24 hours. Rectally administered barium sulfate is eliminated with clearance of the enema [L1959].</metabolism>
  <absorption>Barium sulfate is not absorbed following oral or rectal administration with a normal gastrointestinal tract. In patients with a normal GI tract, barium sulfate is normally excreted within 24 hr after oral ingestion. Post rectal administration of barium sulfate suspensions, the drug is generally excreted when the enema is released. Some barium may remain in the colon for several weeks, however, and eventually clears, especially in patients with impaired intestinal peristalsis [L1957]. It is difficult to quantify the uptake of ingested barium because of a number of factors affect its absorption. The presence of sulfate in food can cause the precipitation of barium sulfate [L1957].&#13;
&#13;
The following is the approximate time to peak opacification of organs by barium sulfate in a healthy GI tract:&#13;
&#13;
Esophagus, stomach, and duodenum uptake of barium sulfate occurs almost immediately after oral administration [L1958].&#13;
&#13;
Small intestine uptake is dependent on gastric emptying rate and viscosity of the preparation; it may be delayed 15-90 minutes post ingestion [L1958].&#13;
&#13;
Small intestine (enteroclysis studies) uptake is immediate, following direct instillation [L1958].&#13;
&#13;
Colon and distal small intestine uptake are dependent on patient positioning. Hydrostatic pressure also determines the rate and degree of opacification [L1958].</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination>Barium sulfate is excreted unchanged in the feces [L1957].</route-of-elimination>
  <volume-of-distribution/>
  <clearance>The rate of excretion of barium sulfate is dependent on the route of administration and the status of peristaltic activity and motility of the gastrointestinal tract [L1959].</clearance>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as alkaline earth metal sulfates. These are inorganic compounds in which the largest oxoanion is sulfate, and in which the heaviest atom not in an oxoanion is an alkaline earth metal.</description>
    <direct-parent>Alkaline earth metal sulfates</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Alkaline earth metal oxoanionic compounds</class>
    <subclass>Alkaline earth metal sulfates</subclass>
    <alternative-parent>Inorganic oxides</alternative-parent>
    <alternative-parent>Inorganic salts</alternative-parent>
    <substituent>Alkaline earth metal sulfate</substituent>
    <substituent>Inorganic oxide</substituent>
    <substituent>Inorganic salt</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="spanish" coder="">Bario sulfato</synonym>
  </synonyms>
  <products>
    <product>
      <name>Anatrast</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-326</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2011-10-31</ended-marketing-on>
      <dosage-form>Paste</dosage-form>
      <strength>560 mg/1g</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Anatrast Pst 55%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00783145</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Paste</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Baricon</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-628</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-04-30</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.98 g/1g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Baricon for Suspension</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00390909</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Baro Bag Enema 98%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00626937</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Enema</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Baro-cat</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-622</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2011-03-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>15 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Barobag Enema Kit</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-066</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2011-10-31</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>.97 g/1g</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Barobag Enema Kit</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-067</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2011-10-31</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>.97 g/1g</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Barocat Susp 1.5%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00776602</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Barosperse</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-621</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-11-30</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>.95 g/1g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Barosperse</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-626</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-11-30</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>.95 g/1g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Barosperse Disposable Enema Units 95%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02096633</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Enema</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Barosperse for Susp 95%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00776629</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cheetah</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241596</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-03-24</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>2.2 %</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cheetah</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-523</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>22 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-Cat Dry</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-727</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-01-01</started-marketing-on>
      <ended-marketing-on>2019-06-01</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>9.5 g/23g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-Cat Dry</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-717</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-09-28</started-marketing-on>
      <ended-marketing-on>2018-08-29</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>400 mg/1g</strength>
      <route>Oral</route>
      <fda-application-number>NDA208036</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-Disk</name>
      <labeller>E-Z-EM, INC.</labeller>
      <ndc-id/>
      <ndc-product-code>10361-778</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength>700 mg/1</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-Dose with Liquid Polibar Plus</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-652</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-11-01</started-marketing-on>
      <ended-marketing-on>2018-08-22</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>1.05 g/1mL</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-HD</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-764</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-01-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>980 mg/1g</strength>
      <route>Oral</route>
      <fda-application-number>NDA208036</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-jug</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00363189</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2001-10-16</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>E-Z-Paque</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-186</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>0.6 g/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-Paque</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-750</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>960 mg/1g</strength>
      <route>Oral</route>
      <fda-application-number>NDA208036</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>E-Z-paque 95%</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01959409</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1997-04-09</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>E-Z-paque Powder for Suspension 95%</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01922173</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2009-08-04</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>E-Z-Paste</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-770</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1974-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength>.6 g/1g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Enhancer</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241556</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-03-24</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength>82 %</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Enhancer</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-527</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-10-31</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.98 g/1g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>ENTERO Vu 24%</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-145</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-09-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>240 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Enterovu - Powder for Suspension 81%</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02175142</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-09-17</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Entrobar</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-322</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2012-10-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>500 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Entrobar Suspension 50%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00652881</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Entroease</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-528</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2010-09-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>130 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Entroease</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243109</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-05-09</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>13 %</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Esobar Crm 65%</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613126</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2005-09-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Evacu Paste 45%</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01929186</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2005-09-26</ended-marketing-on>
      <dosage-form>Paste</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flo-coat</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-327</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-05-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>1000 mg/1mL</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Flo-coat Susp 100%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00776645</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hd 200 Plus</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-128</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-11-30</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.98 g/1g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hd 85</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-029</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2010-10-31</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.85 g/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hd 85 Barium Sulfate Susp 51%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00626902</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hd200 Plus Barium Sulfate for Susp 98%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00626910</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-09</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Intropaste</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-022</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2011-08-31</ended-marketing-on>
      <dosage-form>Paste</dosage-form>
      <strength>440 mg/1g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Intropaste - Pst Orl 44%w/w</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02196204</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Paste</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liqui-coat Hd</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-328</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2010-07-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>2100 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liqui-coat Hd - Sus Orl 210%w/v 81%w/w</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02195569</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liquid Barosperse</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-325</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-06-01</started-marketing-on>
      <ended-marketing-on>2012-09-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>600 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Liquid Barosperse- Sus Orl RT 60%w/v 40%w/w</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02196190</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-09-10</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liquid Polibar Plus</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-168</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1.05 g/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maxibar Liquid 210gm/100ml</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00782262</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2005-09-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Medebar Plus</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-737</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2010-09-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>1000 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Medebar Plus - Sus Orl RT 56%w/w 100%w/v</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02216388</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-05-28</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>NeuLumEX</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-926</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Polibar ACB</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-804</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1978-04-15</started-marketing-on>
      <ended-marketing-on>2018-08-23</ended-marketing-on>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>965 mg/1g</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Polibar Rapid 57% (p/p)</name>
      <labeller>Therapex Division De E Z Em Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01958739</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>2009-08-04</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Prepcat</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-126</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2011-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>150 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prepcat 1.5%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00794260</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Readi-Cat</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-728</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-06-01</started-marketing-on>
      <ended-marketing-on>2015-07-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>13 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat 2</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-724</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat 2 Banana Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-722</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat 2 Berry Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-711</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat 2 Creamy Vanilla Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-756</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat 2 Mochaccino Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-777</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>20 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-723</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1985-06-01</started-marketing-on>
      <ended-marketing-on>2018-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2 Apple Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-735</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-02-01</started-marketing-on>
      <ended-marketing-on>2015-06-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2 Banana Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-725</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-08-01</started-marketing-on>
      <ended-marketing-on>2018-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2 Berry Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-715</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2002-02-01</started-marketing-on>
      <ended-marketing-on>2018-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2 Mochaccino Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-775</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-03-31</started-marketing-on>
      <ended-marketing-on>2018-10-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Readi-Cat2 Vanilla Smoothie</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-755</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2005-11-01</started-marketing-on>
      <ended-marketing-on>2018-12-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Scan C</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-638</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2012-01-31</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tagitol V</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-814</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-08-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>400 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tomo Cat Barium Sulfate Susp 5%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00626929</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2010-01-07</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Tomocat</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-222</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2010-11-30</ended-marketing-on>
      <dosage-form>Suspension</dosage-form>
      <strength>50 mg/1mL</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tonojug</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-226</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2012-09-30</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.95 g/1g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tonopaque</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>68240-223</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-12-01</started-marketing-on>
      <ended-marketing-on>2012-11-30</ended-marketing-on>
      <dosage-form>For suspension</dosage-form>
      <strength>.95 g/1g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tonopaque for Suspension 95%</name>
      <labeller>Tyco Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02096684</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-09</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vanilla SilQ</name>
      <labeller>Genus Medical Technologies, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69307-1024</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2014-10-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>21 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vanilla SilQ HD</name>
      <labeller>Genus Medical Technologies, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69307-4496</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-12-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>98 g/100g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vanilla SilQ MD</name>
      <labeller>Genus Medical Technologies, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69307-4096</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>96 g/100g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Varibar Honey</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-122</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>400 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Varibar Nectar</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-115</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2017-07-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>400 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Varibar Pudding</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-125</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2016-10-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Paste</dosage-form>
      <strength>400 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208844</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Varibar Thin Honey</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-121</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-01-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>400 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA208143</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Varibar Thin Liquid</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-105</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>.81 g/1g</strength>
      <route>Oral</route>
      <fda-application-number>NDA208036</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vizumax ENEM</name>
      <labeller>Vizumax Diagnostics LLC</labeller>
      <ndc-id/>
      <ndc-product-code>71719-2040</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-03-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>960 mg/1g</strength>
      <route>Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vizumax HD</name>
      <labeller>Vizumax Diagnostics LLC</labeller>
      <ndc-id/>
      <ndc-product-code>71719-2030</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2018-01-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Powder, for suspension</dosage-form>
      <strength>980 mg/1g</strength>
      <route>Oral; Rectal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>VoLumen</name>
      <labeller>E-Z-EM Canada Inc</labeller>
      <ndc-id/>
      <ndc-product-code>32909-945</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2003-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength>1 mg/1mL</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Liquid Barosperse</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Medebar Plus</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Scan C</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Intropaste</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tomocat</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Prepcat</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tonopaque</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tonojug</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Liqui-coat Hd</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Hd 200 Plus</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Baricon</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barosperse</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barosperse</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Baro-cat</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barobag Enema Kit</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barobag Enema Kit</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Anatrast</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Entrobar</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Entroease</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Cheetah</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Enhancer</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Flo-coat</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Hd 85</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Dose with Liquid Polibar Plus</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Polibar ACB</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Cat Dry</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2 Banana Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2 Berry Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2 Mochaccino Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2 Vanilla Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-HD</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Paque</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>ENTERO Vu 24%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat2 Apple Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Cat Dry</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Paque</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Paste</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat 2</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat 2 Banana Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat 2 Berry Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat 2 Mochaccino Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Readi-Cat 2 Creamy Vanilla Smoothie</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Varibar Pudding</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tagitol V</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Varibar Thin Honey</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Varibar Honey</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Varibar Nectar</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Varibar Thin Liquid</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Vizumax ENEM</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Vizumax HD</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-Disk</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>VoLumen</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Liquid Polibar Plus</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Vanilla SilQ</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Vanilla SilQ MD</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Vanilla SilQ HD</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>NeuLumEX</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Maxibar Liquid 210gm/100ml</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-paque Powder for Suspension 95%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Evacu Paste 45%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-paque 95%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Polibar Rapid 57% (p/p)</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barosperse Disposable Enema Units 95%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tonopaque for Suspension 95%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Enterovu - Powder for Suspension 81%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Intropaste - Pst Orl 44%w/w</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Liqui-coat Hd - Sus Orl 210%w/v 81%w/w</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Liquid Barosperse- Sus Orl RT 60%w/v 40%w/w</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Medebar Plus - Sus Orl RT 56%w/w 100%w/v</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Esobar Crm 65%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Hd 85 Barium Sulfate Susp 51%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Hd200 Plus Barium Sulfate for Susp 98%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tomo Cat Barium Sulfate Susp 5%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Baro Bag Enema 98%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Enhancer</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Cheetah</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Entroease</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Entrobar Suspension 50%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>E-Z-jug</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barocat Susp 1.5%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Flo-coat Susp 100%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Baricon for Suspension</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Anatrast Pst 55%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Prepcat 1.5%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Barosperse for Susp 95%</name>
      <ingredients>Barium sulfate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Barium Compounds</category>
      <mesh-id>D017609</mesh-id>
    </category>
    <category>
      <category>Barium Sulfate Containing X-Ray Contrast Media</category>
      <mesh-id/>
    </category>
    <category>
      <category>Compounds used in a research, industrial, or household setting</category>
      <mesh-id>D020313</mesh-id>
    </category>
    <category>
      <category>Contrast Media</category>
      <mesh-id>D003287</mesh-id>
    </category>
    <category>
      <category>Diagnostic Uses of Chemicals</category>
      <mesh-id>D064907</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Radiographic Contrast Agent</category>
      <mesh-id/>
    </category>
    <category>
      <category>Sulfates</category>
      <mesh-id>D013431</mesh-id>
    </category>
    <category>
      <category>Sulfur Acids</category>
      <mesh-id>D013456</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Sulfuric Acids</category>
      <mesh-id>D013464</mesh-id>
    </category>
    <category>
      <category>X-Ray Contrast Activity</category>
      <mesh-id/>
    </category>
    <category>
      <category>X-Ray Contrast Media, Non-Iodinated</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Paste</form>
      <route>Rectal</route>
      <strength>560 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>15 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Rectal</route>
      <strength>.97 g/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral; Rectal</route>
      <strength>.95 g/1g</strength>
    </dosage>
    <dosage>
      <form>Enema</form>
      <route>Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral; Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>2.2 %</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>22 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength>400 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength>9.5 g/23g</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>700 mg/1</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Rectal</route>
      <strength>1.05 g/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength>980 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength>960 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>0.6 g/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral; Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Oral</route>
      <strength>.6 g/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Oral</route>
      <strength>82 %</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>240 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>500 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>13 %</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>130 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Paste</form>
      <route>Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Rectal</route>
      <strength>1000 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>For suspension</form>
      <route>Oral</route>
      <strength>.98 g/1g</strength>
    </dosage>
    <dosage>
      <form>For suspension</form>
      <route>Oral; Rectal</route>
      <strength>.85 g/1mL</strength>
    </dosage>
    <dosage>
      <form>Paste</form>
      <route>Oral</route>
      <strength>440 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Paste</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>2100 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>600 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>1.05 g/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>1000 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Rectal</route>
      <strength>965 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>150 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral; Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>13 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>20 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>21 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>21 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>400 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral; Rectal</route>
      <strength>50 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>For suspension</form>
      <route>Oral; Rectal</route>
      <strength>.95 g/1g</strength>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral; Rectal</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral; Rectal</route>
      <strength>98 g/100g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral; Rectal</route>
      <strength>96 g/100g</strength>
    </dosage>
    <dosage>
      <form>Paste</form>
      <route>Oral</route>
      <strength>400 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral</route>
      <strength>.81 g/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Rectal</route>
      <strength>960 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Powder, for suspension</form>
      <route>Oral; Rectal</route>
      <strength>980 mg/1g</strength>
    </dosage>
    <dosage>
      <form>Suspension</form>
      <route>Oral</route>
      <strength>1 mg/1mL</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="V08BA02">
      <level code="V08BA">Barium sulfate containing X-ray contrast media</level>
      <level code="V08B">X-RAY CONTRAST MEDIA, NON-IODINATED</level>
      <level code="V08">CONTRAST MEDIA</level>
      <level code="V">VARIOUS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB11150.pdf?1527261920</fda-label>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11150.pdf?1527262017</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.84</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>barium(2+) ion sulfate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>barium(2+) ion sulfate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>233.39</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>233.856970451</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[Ba++].[O-]S([O-])(=O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>BaO4S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/Ba.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>TZCXTZWJZNENPQ-UHFFFAOYSA-L</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>80.26</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>11.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>5.81</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>-3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Very slightly soluble in cold water</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>1580</value>
      <source>MSDS</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>decomposes</value>
      <source>MSDS</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>6347</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>133326</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>24414</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827920</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>22823</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Barium_sulfate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2105897</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>